Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Argent BioPharma and AusCann enter heads of agreement for cannabinoid drug development
April 15, 2025 - - Latest News -
Botanix secures commitments for $40 million to accelerate Sofdra rollout
April 15, 2025 - - Latest News -
Carina Biotech completes $5 million capital raise
April 15, 2025 - - Latest News -
Noxopharm announces SOF-SKN successfully passes final pre-trial study
April 15, 2025 - - Latest News -
Neuren confirms primary endpoints for Phase 3 Trial of NNZ-2591 in PMS
April 15, 2025 - - Latest News -
Recce announces placement and entitlement offer to support late-stage trial
April 10, 2025 - - Latest News -
Prescient Therapeutics announces the appointment of new non-executive director
April 10, 2025 - - Latest News